Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy

Background: Cytoreductive nephrectomy (CN) became a standard procedure in metastatic renal cell carcinoma (mRCC) in the immunotherapy era. Historically, median overall survival (OS) of patients treated with interferon alpha (IFN-α) without CN was 7.8 months. Median OS in patients treated with target...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Richey, S. L., Culp, S. H., Jonasch, E., Corn, P. G., Pagliaro, L. C., Tamboli, P., Patel, K. K., Matin, S. F., Wood, C. G., Tannir, N. M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2011
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4092250/
https://ncbi.nlm.nih.gov/pubmed/21115604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdq563
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares